RxDoctor Payments Data

Eleazar Dial, PA

Physician Assistant · Riverside, CANPI 1679927834

Payments from drug & device makers

$1,955in general payments, 2019–2025

Across 85 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$383
  • Xeris Pharmaceuticals, Inc.$247
  • Bayer$227
  • Novo Nordisk$207
  • Boehringer Ingelheim$175
  • AstraZeneca$115
  • plus $600 from 10 others

What the payments were for

  • Food & beverage$1,94499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,955 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$3,098
Medicare patients
32
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$105,635
JardianceEmpagliflozin95$58,454
FarxigaDapagliflozin Propanediol75$50,735
TrulicityDulaglutide23$23,374
RybelsusSemaglutide16$14,767
Humalog Kwikpen U-100Insulin Lispro59$8,791
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$7,853
DapagliflozinDapagliflozin Propanediol14$6,291
Nano 2nd Gen Pen NeedlePen Needle, Diabetic49$3,261
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro12$1,626
SynthroidLevothyroxine Sodium22$1,500
Methimazole59$857
Levothyroxine Sodium42$527
Glipizide75$445
Metformin Hcl55$399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$207$120,402125 claims
Boehringer IngelheimJardiance$175$58,45495 claims
AstraZenecaFarxiga$115$50,73575 claims
Lilly USA, LLCTrulicity$80$23,37423 claims
AbbVieSynthroid$77$1,50022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →